US Patent 11053311 Antibodies targeting CDH19 for melanoma
Patent 11053311 was granted and assigned to Amgen on July, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11053311 Antibodies targeting CDH19 for melanoma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.